Tianda Pharmaceuticals Limited announced that Mr. SHEN Bo tendered his resignation as a Non-executive Director with effect from 29 August 2023 due to other work commitment. Mr. SHEN has confirmed that he does not have any disagreement with the Board and there are no matters in relation to his resignation that need to be brought to the attention of the shareholders of the Company and The Stock Exchange of Hong Kong Limited. The Board further announced that Mr. ZHONG Tao has been appointed as a Non-executive Director with effect from 29 August 2023.

The biographical details of Mr. ZHONG is set out below: Mr. ZHONG, aged 51, is currently the vice president, board secretary and joint company secretary of Shanghai Pharmaceuticals Holding Co. Ltd. (a company listed on the Shanghai Stock Exchange with stock code 601607, and the Hong Kong Stock Exchange with stock code 02607). Mr. ZHONG previously served as an executive director and a vice president of Shanghai Industrial Urban Development Group Limited (a company listed on Hong Kong Stock Exchange with stock code 00563); and held several management positions in other companies including Shanghai Industrial Management (Shanghai) Company Limited., Shanghai Galaxy Digital Investment Company Limited., and Shanghai Industrial Real Property Group (Shanghai) Company Limited.

etc. Mr. ZHONG holds a master's degree in Business Management from Fudan University. The Board further announced that Mr. ZHONG is appointed as a member of the audit committee of the Company following his appointment as Non-executive Director of the Company on 29 August 2023; and Mr. SHEN will cease to be a member of the audit committee of the Company following his resignation as Non-executive Director of the Company on 29 August 2023.